TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-08-28
公報種別公開国際商標公報
国際登録番号1796541
国際登録日2024-02-05
区分第5類(薬剤)
商品役務Medicinal, pharmaceutical and veterinary preparations including dietary, nutritional and vitamin food supplements.
基礎出願番号5892890
基礎出願日2023-04-14
基礎出願国IN
出願人APITORIA PHARMA PRIVATE LIMITED
OCRテキスト全。 wm3DIO[a し
OCRテキスト2Capitoria
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

ZEALAND PHARMA A/S
OVOYO
3か月前
Alcon Inc.
TRYPTYR
1か月前
Novo Nordisk A/S
Zembrilio
5日前
Dyne Therapeutics, Inc.
DYNETHERAPEUTICS
1か月前
Orion Corporation
KINPARLEV
4か月前
Premier Foods Group Limited
FUEL10K
2か月前
Alcon Inc.
TRIPTYR
1か月前
ARROWHEAD PHARMACEUTICALS, INC.
REDEMPLO
2か月前
Novo Nordisk A/S
Zilconyc
5日前
Boehringer Ingelheim International GmbH
ATURZURV
1か月前
Boehringer Ingelheim International GmbH
TUSIRGG
1か月前
Boehringer Ingelheim International GmbH
ESREVERTY
1か月前
Boehringer Ingelheim International GmbH
VIMSURQ
1か月前
Boehringer Ingelheim International GmbH
AMZANSU
1か月前
Boehringer Ingelheim International GmbH
MEVORIGG
1か月前
Boehringer Ingelheim International GmbH
PLIMFRI
1か月前
Boehringer Ingelheim International GmbH
JULSURQ
1か月前
Boehringer Ingelheim International GmbH
SYDUANC
1か月前
Boehringer Ingelheim International GmbH
LALUMNIS
1か月前
Boehringer Ingelheim International GmbH
INMOSHAY
1か月前
Boehringer Ingelheim International GmbH
VEODREE
1か月前
Boehringer Ingelheim International GmbH
SEVWELQ
1か月前
Boehringer Ingelheim International GmbH
HELTIAM
1か月前
Boehringer Ingelheim International GmbH
IVATELGG
1か月前
Boehringer Ingelheim International GmbH
KEMSELGG
1か月前
Boehringer Ingelheim International GmbH
JUELYRO
1か月前
Invizi IP Pty Ltd
INVIZI
1か月前
Boehringer Ingelheim International GmbH
BEKTUYU
1か月前
Invizi IP Pty Ltd
NUNDIES
1か月前
Boehringer Ingelheim International GmbH
UPTALSU
1か月前
Boehringer Ingelheim International GmbH
POSVIMENTO
1か月前
Boehringer Ingelheim International GmbH
TUPHELTI
1か月前
T.G. Eakin Limited
FREESEALAIR
1か月前
Boehringer Ingelheim International GmbH
HELTIAME
1か月前
Boehringer Ingelheim International GmbH
EMWELTI
1か月前
Boehringer Ingelheim International GmbH
BRYSURQ
1か月前
続きを見る